Title for MeetingAbstracts
Alphabetical listing of titles
Pharmacokinetic and Clinical Studies of a New Ketolide Antimicrobial, Telithromycin (HMR3647) in Otorhinolaryngology.
Pharmacokinetic and clinical studies with three different maintenance doses of pentamidine i.v. in the treatment of severe Pneumocystis carinii pneumonia.
Pharmacokinetic and In Vivo Efficacy Evaluation of a Novel Class of Quinoline-Indole Antibacterial Agents.
Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing.
Pharmacokinetic and Safety Profiles of LB80380, a Novel Acyclic Phosphonate Nucleotide, as a New Anti-HBV Drug Candidate.
Pharmacokinetic and Virologic Response to Ritonavir (RTV) in Combination with Zidovudine (ZDV) and Lamivudine (3TC) in HIV-1 Infected Pregnant Women and Their Infants.
Pharmacokinetic aspects of a therapeutic drug monitoring of azidothymidine in AIDS patients.
PHARMACOKINETIC COMPARISON OF SINGLE VERSUS DOUBLE BOOSTED PROTEASE INHIBITOR REGIMEN: EFFECTIVE SAQUINAVIR LEVELS BY CO-ADMINISTRATION WITH LOPINAVIR/RITONAVIR.
Pharmacokinetic disposition of GLQ223 in patients with AIDS and ARC following intravenous administration.
Pharmacokinetic Drug Interaction and Long Term Safety Profile of Tenofovir DF and Lopinavir/Ritonavir.
Pharmacokinetic drug interactions with amprenavir.
Pharmacokinetic Evaluation of the Combination of Atazanavir (ATV), Enteric Coated Didanosine (ddI-EC), and Tenofovir Disoproxil Fumarate (TDF) for a Once-Daily Antiretroviral Regimen.
Pharmacokinetic Interaction between Didanosine (ddI) and Allopurinol in Healthy Volunteers.
Pharmacokinetic interaction between efavirenz (EFV) and nelfinavir mesylate (NFV) in healthy volunteers.
Pharmacokinetic interaction between efavirenz (EFV) and rifampin (RIF) in healthy volunteers.
Pharmacokinetic interaction between efavirenz/abacavir and methadone in patients under directly observed treatment (DOT) and dosage adjustment over 60 weeks.
Pharmacokinetic Interaction between Lopinavir/r and Amprenavir in Salvage Therapy.
Pharmacokinetic interaction between nevirapine and indinavir and correlation with antiviral activity.
Pharmacokinetic interaction between rifampin (RIF) and zidovudine (ZDV).
Pharmacokinetic Interaction between Rifampin and the Twice-daily Combination of Indinavir and Low-dose Ritonavir in HIV-infected Patients.
Pharmacokinetic Interaction between Roxithromycin and Lovastatin in Volunteers.
Pharmacokinetic interaction between TMC114/ritonavir (RTV) and tenofovir in healthy volunteers.
Pharmacokinetic Interaction between Ultrase[[TM]] MT-20 and Nelfinavir in HIV-infected Individuals.
Pharmacokinetic Interactions between Nelfinavir and Two HMG-CoA Reductase Inhibitors Simvastatin and Atorvastatin.
Pharmacokinetic interactions between protease inhibitors and selected HMG-CoA reductase inhibitors.
Pharmacokinetic interactions between protease inhibitors and selected HMG-CoA reductase inhibitors.
Pharmacokinetic interactions between rifampin and efavirenz in patients with tuberculosis and HIV infection.
Pharmacokinetic interactions with oral ganciclovir: zidovudine, didanosine, probenecid.
Pharmacokinetic of methadone (M) in drug users (DU) taking methadone who start HAART with nevirapine (NVP) once daily.
Pharmacokinetic Parameters and Virological Response to the Combination of Lopinavir/Ritonavir (LPV/r) and Amprenavir (APV) in HIV-Infected Patients with Multiple Treatement Failures: Week-6 Results of Puzzle 1-ANRS Study.